Aimmune Therapeutics Inc buy marge
Start price
20.11.17
/
50%
€31.58
Target price
01.01.19
€36.08
Performance (%)
-31.68%
End price
01.01.19
€21.58
Summary
This prediction ended on 01.01.19 with a price of €21.58. The BUY prediction by marge for Aimmune Therapeutics Inc performed very badly with a performance of -31.68%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aimmune Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -2,20 % | 0,67 % | 0,55 % | 51,11 % |
| iShares Nasdaq 100 | -2,63 % | 2,99 % | 34,11 % | 91,99 % |
| iShares Nikkei 225® | -2,02 % | 3,14 % | 53,42 % | 65,85 % |
| iShares S&P 500 | -1,67 % | 2,40 % | 23,22 % | 66,64 % |
Comments by marge for this prediction
In the thread Aimmune Therapeutics Inc diskutieren
marge stimmt der Outperform-Einschätzung der institutionellen Analysten zu
marge stimmt am 20.11.2017 der Outperform-Einschätzung der institutionellen Analysten zu.
- Aimmune Therapeutics (NASDAQ:AIMT) initiated with Buy rating and $60 (71% upside) price target by Roth Capital.
(Laufzeit überschritten)
Stopped prediction by marge for Aimmune Therapeutics Inc
Aimmune Therapeutics Inc
Start price
Target price
Perf. (%)
€19.28
06.09.19
06.09.19
€30.00
04.11.21
04.11.21
51.45%
05.11.21
05.11.21
